Perspectives in AML treatment: targeting apoptosis without chemotherapy by using BH3-mimetics
2 years on: Deborah discusses her venetoclax trial and becoming MRD negative
Deborah Henderson et al.
How the treatment of AML will change
Mary Frances McMullin
The current status of CLL treatment
Current research to overcome T-cell dysfunction in CLL and improve therapies